Aurora Kinases and Potential Medical Applications of Aurora Kinase Inhibitors: A Review

Journal of Clinical Medicine Research
Paschalis GavriilidisDimitrios Giakoustidis

Abstract

Aurora kinases (AKs) represent a novel group of serine/threonine kinases. They were originally described in 1995 by David Glover in the course of studies of mutant alleles characterized with unusual spindle pole configuration in Drosophila melanogaster. Thus far, three AKs A, B, and C have been discovered in human healthy and neoplastic cells. Each one locates in different subcellular locations and they are all nuclear proteins. AKs are playing an essential role in mitotic events such as monitoring of the mitotic checkpoint, creation of bipolar mitotic spindle and alignment of centrosomes on it, also regulating centrosome separation, bio-orientation of chromosomes and cytokinesis. Any inactivation of them can have catastrophic consequences on mitotic events of spindle formation, alignment of centrosomes and cytokinesis, resulting in apoptosis. Overexpression of AKs has been detected in diverse solid and hematological cancers and has been linked with a dismal prognosis. After discovery and identification of the first aurora kinase inhibitor (AKI) ZM447439 as a potential drug for targeted therapy in cancer treatment, approximately 30 AKIs have been introduced in cancer treatment.

Citations

Dec 23, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Vadim Bernard-GauthierRalf Schirrmacher
Mar 18, 2016·Biological & Pharmaceutical Bulletin·Nhung Thi My HoangKhanh Thi Van Bui
Mar 22, 2016·Clinical and Experimental Pharmacology & Physiology·Cameron T DurlacherShu-Feng Zhou
Apr 15, 2016·Expert Opinion on Drug Discovery·D DubeP Kaur
Jul 30, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Boopathi SubramaniyanGaneshan Mathan
Jun 12, 2016·Biochimica Et Biophysica Acta·Rudra ChhajerNahid Ali
Jul 23, 2016·Leukemia Research·Ana Paula Nunes Rodrigues AlvesFabiola Traina
Oct 31, 2016·Journal of Cellular Physiology·Paolo Chieffi
Feb 17, 2017·Pediatric Blood & Cancer·C M Zwaan, M L Den Boer
Jan 20, 2017·Technology in Cancer Research & Treatment·Mei CaoJian Zhao
Jan 15, 2019·Recent Patents on Anti-cancer Drug Discovery·Paolo ChieffiFrancesco Esposito
Aug 9, 2018·International Journal of Computer Assisted Radiology and Surgery·Austin J TaylorZion Tsz Ho Tse
Jul 11, 2019·Scientific Reports·Keli LimaJoão Agostinho Machado-Neto
Mar 6, 2017·Journal of Experimental & Clinical Cancer Research : CR·Ming LiZeng-Fu Shang
Sep 10, 2019·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Hyang-Ae LeeKi-Suk Kim
Mar 14, 2020·Expert Review of Anticancer Therapy·Paolo ChieffiFrancesco Esposito
Jul 28, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Nicola MicaleMariateresa Cristani
Mar 29, 2020·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Taciani de Almeida MagalhãesKleiton Silva Borges
Dec 23, 2020·Integrative Cancer Therapies·Yanlei XuChang Yao
Feb 6, 2018·Journal of Chemical Information and Modeling·Hwangseo ParkSungwoo Hong
Oct 31, 2021·Reproductive Biology and Endocrinology : RB&E·Peng-Chao WangZeng-Ming Yang

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
xenograft
transgenic
xenografts

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Current Opinion in Investigational Drugs
Krishna S NaruganahalliAbhijit Ray
Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia
Madhu KollareddyMarian Hajduch
Investigational New Drugs
Madhu KollareddyMarian Hajduch
© 2021 Meta ULC. All rights reserved